AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2024
Dec 5, 2024
30870_dirs_2024-12-05_4bde3a21-fb2e-4e1b-ad25-164d3ea289c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-12-03
Reporting Person: Lee Sung (EVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-03 | Common Stock | A | 4303 | — | Acquired | 38987 | Direct |
| 2024-12-03 | Common Stock | F | 1536 | $51.51 | Disposed | 37451 | Direct |
| 2024-12-03 | Common Stock | A | 4304 | — | Acquired | 41755 | Direct |
Footnotes
F1: Transaction represents gross shares of common stock received by grantee upon vesting of Performance Stock Units ("PSUs").
F2: Transaction represents withholding of shares to satisfy grantee's tax obligations in connection with vesting PSUs.
F3: Transaction represents shares of PSUs whose performance condition was satisfied but that remain subject to time-based vesting. These PSUs to vest in full December 3, 2025.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18